... policy based on their economic interests. In Europe , meanwhile, the course to reduce dependence on Russian energy carriers continues. Imports of Russian oil and petroleum products to the EU have been effectively halted by the existing embargo, and pipeline gas supplies have been reduced to minimal levels. The European Union is actively developing infrastructure for receiving LNG (new terminals are being built, and long-term contracts are being signed with alternative suppliers) to replace the volumes ...

... declines from COVID-19 products and withstand competition from generics. Investors will pay close attention to sales of the flagship immunotherapy, Keytruda, and the Gardasil vaccine. Also of focus will be comments about progress in new drug development (pipeline) that could help in future replenishments for expiring patent drugs. If financial results exceed forecasts (e.g., due to unexpectedly high vaccine or new drug sales) or the company raises its annual guidance, MRK shares may receive support. Conversely,...